Article Text
Therapeutics
Randomised controlled trial
In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding
Statistics from Altmetric.com
Footnotes
-
Competing interests RDL and DAG are members of the ARISTOTLE trial's Steering Committee.